Nate Damen is a Research Engineer I with Aerospace, Transportation and Advanced Systems Laboratory of Georgia Tech Research Institute. Damen’s work at ATAS has focused on Mixed Reality applications, robotics, the automation of CAR-T cellular expansions, and bioreactor design. Before joining GTRI, Damen conducted research into the manipulation of textiles with Softwear Automation and the design of deformable parcel manipulation systems with Dorabot. His creative work ATLTVHEAD with the Atlanta Beltline Inc., includes the creation of several wearable electronic systems for remote computing and novel interactions between wearable systems and live user input from those walking the Atlanta Beltline. 

Dr. Leslie Chan is an Assistant Professor in the Wallace H. Coulter Department of Biomedical Engineering at the Georgia Tech School of Engineering and Emory School of Medicine. Her research program integrates core and emerging principles from drug delivery, biomaterials development, and chemical biology to engineer diagnostic and therapeutic solutions for infectious disease, microbiome dysbiosis, and inflammatory diseases. Dr. Chan earned her B.S. in Biomedical Engineering from Georgia Tech and her Ph.D. in Bioengineering from the University of Washington with Professor Suzie Pun. She completed her postdoctoral training at Massachusetts Institute of Technology with Professor Sangeeta Bhatia. Dr. Chan is the recipient of an NIH K99/R00 Pathway to Independence Award.

Dr. Bhasin's laboratory has developed strategies for analysis of transcriptome, epigenome, and proteomics data to perform multi-scale modeling of interaction among different cells molecular level and to identify novel biomarkers. He and his team are currently focusing on developing novel single-cell omics approaches to understand disease heterogeneity and the impact of treatments at single-cell resolution. He is involved in developing approaches for the analysis of multi-dimensional single-cell data by developing innovative approaches for single-cell sparsity, batch correction, annotation, and integration. Using these approaches, his group is working toward understanding: 1. Understanding heterogeneity and relapse mechanisms in pediatric hematological malignancies 2. Understanding heterogeneity and progression in multiple myeloma. 3. Development of molecular diagnostics platforms for cancer diagnosis and prognosis 4. Identification of biomarkers for early detection of pancreatic cancer, glioblastoma, and colon cancer 5. Artificial intelligence-based histopathology and radiology cancer image analysis approaches 6. Single-cell Atlas for Pediatric Cancers Additionally, our group is also developing Biomarkers associated with impaired healing of Diabetic Foot Ulcers using single-cell profiling and deep learning-driven wound image analysis. We are working collaboratively to develop innovative genomics and clinical data-driven drug repurposing approaches.